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Introduction
Tributyltin (TBT) is one of the most toxic xenobiotics 
deliberately introduced into the environment by Man 
(Goldberg, 1986). It has been employed in a variety of 
industrial processes and it is subsequently discharged 
into the environment (Gadd, 2000). Production, use 
and export of TBT have been prohibited in developed 
countries since the 1990s by the International Maritime 
Organization (IMO). The European Union (EU) intro-
duced Directive 2002/62/EC, which forbids the use of 
TBT in any boat after 2008. However, considering the 
long half life of TBT, it is likely that it will remain in the 
water column and sediments for up to 20 years after 
the cessation of TBT inputs into the environment. TBT 
is toxic to eukaryotes and prokaryotes. Examples of 
the effects of TBT in eukaryotes are the imposex (Bar-
roso et al., 2000), which is the superimposition of male 
characters onto gastropod females, and immune sys-
tem inhibition and endocrine disruption in humans 
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The mechanism of bacterial resistance to tributyltin (TBT) is still unclear. The results herein pre-
sented contribute to clarify that mechanism in the TBT-resistant bacterium Aeromonas mollusco-
rum Av27. We have identified and cloned a new gene that is involved in TBT resistance in this 
strain. The gene is highly homologous (84%) to the Aeromonas hydrophila-sugE gene belonging 
to the small multidrug resistance gene family (SMR), which includes genes involved in the trans-
port of lipophilic drugs. In Av27, expression of the Av27-sugE was observed at the early logarith-
mic growth phase in the presence of a high TBT concentration (500 M), thus suggesting the 
contribution of this gene for TBT resistance. E. coli cells transformed with Av27-sugE become 
resistant to ethidium bromide (EtBr), chloramphenicol (CP) and tetracycline (TE), besides TBT. 
According to the Moriguchi logP (miLogP) values, EtBr, CP and TE have similar properties and 
are substrates for the sugE-efflux system. Despite the different miLogP of TBT, E. coli cells trans-
formed with Av27-sugE become resistant to this compound. So it seems that TBT is also a sub-
strate for the SugE protein. The modelling studies performed also support this hypothesis. The 
data herein presented clearly indicate that sugE is involved in TBT resistance of this bacterium. 
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(Dubey et al., 2006). In bacteria, the interference with 
biological membranes (Cooney and Wuertz, 1989; 
Cruz et al., 2012) and the inhibition of amino acid up-
take and growth (Jude et al., 1996; Singh and Bragg, 
1979) has been reported.
Some microorganisms are able to resist/degrade 
TBT (Cruz et al., 2007; Mimura et al., 2008; Suzuki and 
Fukagawa, 1995), this being a phenomenon of rele-
vance to the environmental cycling of this compound. 
Considering TBT tolerance/resistance of bacteria, vari-
ous possible mechanisms have been proposed: (i) 
TBT efflux systems (Fukagawa and Suzuki; 1993; Her-
nould et al., 2008; Jude et al., 2004); ii) transformation 
into less toxic compounds (dibutyltin, DBT and mono-
butyltin, MBT) by biotic and abiotic factors (Cruz et al., 
2007; Pain and Cooney, 1998); (iii) degradation/meta-
bolic utilization as a carbon source (Cruz et al., 2007; 
Kawai et al., 1998) and (iv) bioaccumulation into the 
cell without breakdown of the compound (Dubey and 
Roy, 2003). All together, these findings suggest that 
the mechanism of TBT resistance is quite complex and 
not unique among different bacterial strains. Neverthe-
less, so far, the resistance mechanism has not been 
fully elucidated in bacteria.
Aeromonas molluscorum Av27 was isolated from a 
moderately TBT-polluted marine sediment and it is 
highly resistant to TBT (up to 3 mM) (Cruz et al., 2007). 
Previous studies reported the degradation of TBT to 
DBT and MBT, and also its use as a carbon source by 
the Av27 strain (Cruz et al., 2007). A chromosomal 
fragment from this strain was isolated and cloned in E. 
coli HB101, conferring resistance to TBT to those cells 
(Cruz et al., 2010). The complete open reading frame 
(ORF) of that fragment has high homology with A. hy-
drophila-sugE, encoding the SugE protein. SugE be-
longs to the small multidrug resistance family (SMR) 
and it is involved in the transport of lipophilic drugs 
(Sikora and Turner, 2005). Herein, we show that the 
expression of Av27-sugE is triggered in response to 
TBT. The selective effect of resistance to xenobiotics, 
including to TBT, was also investigated. A theoretical 
model of Av27-SugE protein was obtained that con-
tributes to the understanding of TBT transport into the 
bacterial cell.
Materials and Methods
Bacterial strains and growth conditions. ​Aeromon-
as molluscorum Av27 was isolated from sediment col-
lected at Ria de Aveiro, Portugal (Cruz et al., 2007). 
The strain was maintained on Tryptic Soy Agar (TSA) 
plates (Merck, Germany) at 4°C. Growth in liquid cul-
ture of Av27 and E. coli HB101 occurred in Tryptic Soy 
Broth, TSB (Merck) at 26°C and in LB-Bouillon Miller 
broth, LB (Merck) at 37°C, respectively, and at 250 
rpm. Cloning and sub cloning experiments were made 
in E. coli HB101 (Promega, USA). When necessary, 
the following selective agents were added to the 
growth media: ampicillin at 50 µg ml-1 and TBTCl 
(97%) (Fluka, Switzerland) at 0.05 to 3 mM. Hereafter, 
TBTCl will be referred as TBT. In all the experimental 
conditions where TBT was added, procedures were 
performed in the dark to avoid compound degrada-
tion.
Av27-sugE: a gene involved in TBT resistance.  A 
genomic library of Av27 was constructed as described 
by Cruz et al. (2010). In one clone (clone 69) (Cruz et 
al., 2010), highly resistant to TBT, four ORFs were 
identified. Each ORF was amplified, subcloned in 
pUC19 vector and transformed in E. coli HB101.
TBT resistance of each subclone was confirmed by 
growth in LB medium supplemented with ampicillin 
(50 µg ml-1), with (100 µM) and without TBT, at 37°C 
and 250 rpm. Growth was recorded as a change of 
optical density at 600 nm. pUC19 vector transformed 
into E. coli HB101 was used as the negative control. 
One subclone (ORF P6: Av27-sugE) showed a similar 
growth pattern to that of the original clone 69 and was 
therefore selected for further studies and characteriza-
tion.
Expression analysis of Av27-sugE.  Expression of 
Av27-sugE in A. molluscorum Av27 was investigated 
by Real Time-qPCR. The strain was grown in the pres-
ence of three different concentrations of TBT (0, 100 
and 500 µM) at 26°C and 120 rpm. To improve the ac-
curacy of the results, seven independent replicates 
were prepared for each condition. At an optical density 
(A600nm) of 0.2 (early growth phase), 0.5 (mid growth 
phase) and 1 (late growth phase) the cells were pel-
leted by centrifugation and immediately frozen at 
-80°C. Total RNA was extracted with the RNeasy Mini 
kit (Qiagen, Germany) and DNA was completely re-
moved with the Turbo DNA-free kit (Ambion, USA) ac-
cording to the supplier’s instructions. RNA concentra-
tion and integrity were determined with the Nanodrop 
(Thermo Scientific, USA) and by agarose gel electro-
phoresis. One microgram of RNA was used for reverse 
transcription (RT) reaction using the ReverTra Ace 
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qPCR RT Kit (TOYOBO, Japan). RT-qPCR was per-
formed in the Applied Biosystems StepOne equip-
ment, using the Fast SYBR Green Master Mix kit (Ap-
plied Biosystems, USA) according to the manufacturer’s 
instructions. A control sample (with and without RT 
enzyme) was also included in the analysis. Specific 
primers (5′- ATG CCC TGG ATA TTG CTG CTC- 3′ and 
5′- GGG TGA AAC CTT GGG TGT ATT TG- 3′) to am-
plify Av27-sugE gene were designed based on the 
Av27-sugE sequence, using the Primer3Plus program 
available at http://www.bioinformatics.nl/cgi-bin/ 
primer3plus/primer3plus.cgi. The 16S rRNA gene was 
included as the internal standard. The relative quantity 
of gene expression was calculated using the ∆∆Ct 
method (Biosystems, 2004). Statistical analysis was 
performed with GraphPad Prism5 (GraphPad Soft-
ware, Inc., USA).
Modelling of Av27-SugE protein.  A theoretical 
model of Av27-SugE protein using MODELLER (Sali 
and Blundell, 1993), employing the Escherichia coli 
EmrE cryomicroscopy structure (Ubarretxena-Be-
landia et al., 2003) as the template (protein databank 
code: 2I68), was constructed. The complete Av27-
SugE protein and EmrE protein sequence share 34% 
sequence identity. Only the transmembrane helices of 
EmrE were experimentally determined; hence, only 
the transmembrane helices of Av27-SugE protein were 
modelled. This corresponds to the Av27-SugE protein 
residue segments: 3‒20, 33‒51, 57‒79, 87‒104, 
107‒124, 141‒155, 161‒180, 190‒207. These seg-
ments correspond to the four transmembrane 
α-helices of each monomer. 20 models were generat-
ed using an initial alignment between the Av27-SugE 
protein and EmrE protein sequence carried out with 
MODELLER. The model with the lowest objective func-
tion (Sali and Blundell, 1993) was chosen and its qual-
ity was evaluated based on the stereochemistry of the 
generated model given by Procheck (Laskowski et al., 
1993).
Determination of minimum inhibitory concentration 
(MIC).  The resistance profiles of E. coli HB101 trans-
formed either with Av27-sugE (E. coli HB101/Av27-
sugE) or pUC19 vector (E. coli HB101/pUC19) to sev-
eral chemicals were determined and compared. A 
broad range of toxic compounds, including represen-
tatives of cationic dyes, and neutral and anionic anti-
microbials were used. The following compounds were 
tested: (i) cationic dyes: ethidium bromide (Appli-
chem, USA, stock solution at 6 mg ml-1 prepared in 
distilled water), proflavine (Sigma-Aldrich, Germany, 
stock solution at 1 mg ml-1 prepared in distilled water), 
crystal violet (Merck, stock solution at 1 mg ml-1 pre-
pared in absolute ethanol), cetylpyridinium chloride 
(Sigma-Aldrich, stock solution at 1 mg ml-1 prepared 
in distilled water); (ii) neutral antimicrobial: chloram-
phenicol (Biochemical, England, stock solution at 
25 mg ml-1 prepared in absolute ethanol); (iii) other 
antimicrobial: tetracycline (Sigma-Aldrich, stock solu-
tion at 12.5 mg ml-1 prepared in absolute ethanol) and 
(iv) organotin compounds: TBT (stock solution at 0.1 M 
prepared in absolute ethanol), dibutyltin (Fluka, stock 
solution at 0.1 M prepared in absolute ethanol).
Serial twofold dilutions of the drugs were analyzed 
using the microwell dilution assay. Serial dilutions of 
each drug to be tested were prepared in LB medium 
containing ampicillin (150 µg ml-1). After placing 100 µl 
of these dilutions into the 96-well plates, 100 µl of the 
bacterial cultures (E. coli HB101/Av27-sugE and E. coli 
HB101/pUC19), previously grown in LB medium con-
taining ampicillin and with turbidity adjusted to 0.5 Mc-
Farland standard, were also added to the wells. Con-
trols were prepared as above but no drug was added. 
The final volume in each well was 200 µl. The plates 
were covered with sterile plate sealers and incubated 
at 37°C for 24 h. Microbial growth was recorded at an 
optical density at 595 nm, with a microwell plate read-
er (iMarkTM microplate reader, Biorad, USA). All the 
tests were performed in triplicate.
Statistical analyses.  Statistical analyses of the data 
obtained in the gene expression and MIC experiments, 
were performed with GraphPad Prism 5 (GraphPad 
software, Inc., USA). One-way univariate analysis of 
variance model (ANOVA) was used, followed by the 
Tukey test to discriminate significant differences 
among all the tested conditions. A value of p＜0.05 
was considered significant.
Nucleotide sequence accession number.  The nu-
cleotide sequence of ORF P6 (encoding Av27-sugE) is 
deposited in the GenBank under the accession # 
FJ225136.
Results and Discussion
Av27-sugE gene is involved in TBT resistance
Subcloning of ORF P6 (Av27-sugE) conferred phe-
notypic resistance to TBT to E. coli HB101 cells. This 
clone contained the pUC19 vector with an inserted 
fragment of 315 bp, whose deduced amino acid se-
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quence has high homology (84% homology) to the 
SugE protein of A. hydrophila. SugE belongs to the 
small multidrug resistant family (SMR). Proteins be-
longing to this family are small (~12 kDa) integral in-
ner membrane proteins. In the case of Av27-SugE, the 
hydropathy profile (data not shown) revealed that the 
protein is highly hydrophobic, like other members of 
the SMR family. These are characterized by spanning 
the cytoplasmic membrane as four transmembrane 
(TM) α-helices (Paulsen et al., 1996b) with short hy-
drophilic loops which make them very hydrophobic 
(Yerushalmi et al., 1996).
sugE expression in Av27 strain
Av27-sugE expression was investigated, in the Av27 
strain, in the presence and absence of TBT. As shown 
in Fig. 1, when cells grow without TBT, the Av27-sugE 
gene is only expressed at a residual level (relative ex-
pression level lower than 5), independently of the 
growth phase of the cells. The same results were ob-
served when cells were grown in the presence of 
100 µM of TBT. However, different relative expression 
levels were observed when TBT was added at 500 µM. 
The expression of Av27-sugE was significantly higher 
at the early growth phase (Fig. 1A) (p＜0.05), whereas 
at the mid and late growth phase (Fig. 1B, C), no sig-
nificant differences were observed. These results indi-
cate that the expression of Av27-sugE occurred at a 
high concentration of TBT and specifically increased 
at the early growth phase. At later growth phases no 
expression of Av27-sugE was observed. Since Av27 is 
highly resistant to TBT (Cruz et al., 2007) it appears 
that concentrations of 100 µM of TBT are not high 
enough to trigger the relative expression of Av27-sugE, 
although this concentration can inhibit the growth of 
other bacteria, for instance Shewanella algae/putrefa-
ciens Av35 or Bacillus firmus Av3 (Cruz et al., 2007). 
Still, a higher concentration of TBT, for instance 500 µM, 
which is considered to be lethal for most bacteria 
(Cruz et al., 2007), seems to induce the expression of 
this gene, allowing bacteria to cope with the presence 
of the compound. These results confirm the role of 
Av27-sugE in the TBT resistance exhibited by this 
strain.
Since the relative expression of Av27-sugE was only 
observed in the early growth phase it seems that this 
rapid response to TBT is similar to that observed with 
iron-repressible outer membrane proteins of Actinoba-
cillus pleuropneumoniae. In that strain a similar rapid 
expression induction was observed on iron-repressi-
ble outer membrane proteins within 15 to 20 min after 
establishment of iron starvation (Nielsen and Boye, 
2005). Similarly, in another study with E. coli, growth 
phase-dependent expression was reported for other 
genes, namely mdtEF, encoding MdtEF protein, a ma-
jor drug exporter that confers drug tolerance (Ko-
bayashi et al., 2006). The E. coli-sugE gene encodes a 
chaperonin-related system whose composition might 
vary with temperature and growth phase. In that case, 
two expression models were proposed for sugE regu-
lation permitting both i) constitutive and ii) stress-in-
duced expression dependent on a still-undefined sig-
ma factor (Greener et al., 1993). In the present study, 
Av27-sugE was constitutively expressed, and its ex-
pression was induced by the stress caused by TBT. 
Thus, it seems that both models are occurring simulta-
Fig. 1. Relative expression levels of Av27-sugE gene of A. molluscorum Av27.
Cells were grown without (0) and with TBT (100 and 500 µM). Samples were analyzed at different growth 
phases. A: early log phase (OD600nm=0.2), B: mid log phase (OD600nm=0.5) and C: late log phase 
(OD600nm=1). Values were normalized against 16S rRNA, the internal standard and each sample was run in 
triplicate. * A value of p＜0.05 was considered significant.
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neously in Av27-sugE.
A model of Av27-SugE suggests a possible efflux of 
TBT
In order to perform TBT efflux and SMR substrate 
resistance experiments, we tried to generate a mutant 
containing disrupted Av27-sugE. Several attempts 
were made that involved transformation and transcon-
jugation methods with no success. That was probably 
due to the intrinsic properties of the Av27 strain. Like-
wise, other authors reported the same impairment with 
A. hydrophila strains (Bello-López et al., 2012).
Nevertheless, we were determined to understand 
the role of SugE in TBT transport. With that purpose, 
the modelling of Av27-SugE protein (Fig. 2) was per-
formed. The protein structure was based on the cryo-
microscopy structure of EmrE from E. coli (Ubarretxe-
na-Belandia et al., 2003) and from the latest reanalyzed 
EmrE X-ray data from Chen et al. (2007). Both experi-
mental studies support an antiparallel homodimer 
quaternary structure forming a channel with TM heli-
ces TM1, TM2 and TM3; therefore, our theoretical 
model has also an antiparallel quaternary structural 
arrangement. Furthermore, only the TM helical struc-
tures were modelled due to the lack of structural data 
for the loop regions connecting the TM sections. The 
superposition of the Cα α-helix residues of our model 
with the EmrE cryomicroscopy structure gives an aver-
age root mean square displacement (RMSD) of 1.4 Å.
The precise location of the conserved and functional 
residues of the SUG protein subclass (represented by 
SugE from Citrobacter freundii) is shown on Fig. 2. 
Specific conserved SUG residues (position 39, 43 and 
44) identified by Bay et al. (2008) are located facing 
the substrate binding chamber and interfacing the dif-
ferent TM helices. Av27-SugE protein does not have 
the same conserved residues, isoleucine 43 and ala-
nine 44, that were found in SugE. In Av27-SugE pro-
tein, position 43 is occupied by a valine (equivalent 
nonpolar residue like isoleucine) and position 44 is 
filled with a leucine, a bulkier aromatic residue than 
alanine. Furthermore, Av27-SugE protein contains the 
highly conserved glutamate residue (Glu 13, see Fig. 
2) located in the inner part of the binding chamber.
SMR family proteins are involved in the transport of 
lipophilic compounds, primarily quaternary ammoni-
um compounds (QAC) as well as a variety of antibiot-
ics (Chung and Saier, 2002; McIntosh et al., 2008), 
commonly used antiseptics, and detergents. These 
proteins are also responsible for drug efflux via an 
electrochemical proton gradient (Grinius and Gold-
berg, 1994; Yerushalmi et al., 1996) being classified as 
proton-dependent multidrug efflux systems (Paulsen 
et al., 1996a). The modelling studies of Av27-SugE 
herein performed allowed us to predict the predomi-
nance of nonpolar residues, along the α-helix struc-
ture of Av27-SugE protein, which is in agreement with 
its transmembrane location and the nonpolar charac-
teristic of the binding chamber, essential for the pro-
tein association and the translocation of nonpolar sol-
utes like TBT. Furthermore, it is also clear that some 
polar residues (including charged residues) are found 
in the transmembrane sections. The presence of 
charged residues is also essential for the proposed 
biochemical proton-dependent translocation mecha-
nism of this small multidrug resistance protein family 
(Muth and Schuldiner, 2000). Av27-SugE contains also 
aromatic residues Y59 and W62 that are highly con-
served in SMR proteins, which have been described 
as being involved in protein-drug interactions (Sikora 
Fig. 2. Structural model of the Av27-SugE protein.
Location of the conserved and functional residues of 
Av27-SugE (in both monomers) that are specific to the SUG 
subclass (Bay et al., 2008). The Cα of the conserved resi-
dues of the SUG subclass is rendered as dark grey spheres. 
Location of the Glu 13 residue is also indicated on the figure 
and rendered as light grey spheres. Position of the essential 
residues for substrate binding studied by Son et al. (2003) 
(39, 43 and 44) is labelled on the figure and rendered as 
light grey spheres. Residues labelled with (1) indicate point 
mutations relative to SugE (Citrobacter freundii) protein de-
scribed by Son et al. (2003). See text for details.
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and Turner, 2005).
Amino acid sequence alignment of Av27-SugE from 
A. molluscorum Av27, with other SMR proteins depos-
ited in the databases, namely SugE from A. hydrophila 
7966 (the closest homology, 84%) and SugE from E. 
coli K12 (ancestor of E. coli HB101, used in our clon-
ing experiments) (Fig. 3) revealed some nucleotide 
and amino acids changes. An amino acid substitution 
was found at position 24, which has been reported to 
be related with substrate specificity in SugE and other 
SMRs (Son et al., 2003). This substitution may be in-
volved in the substrate selection, namely on the bind-
ing of TBT. Some common amino acids were found in 
the SugE of Av27 and A. hydrophila, which were differ-
ent from those found in E. coli. These might also be 
related to the intrinsic TBT resistance of some Aeromo-
nas species and the susceptibility of the E. coli strain 
used in the present study.
Susceptibility to chemicals by Av27-sugE transformed 
E. coli
It has been shown that proteins belonging to the 
SMR family are involved in the export of drugs from 
bacterial cells, namely cationic drugs that are believed 
to translocate their substrates via a fairly hydrophobic 
transmembrane pathway (Mordoch et al., 1999). To 
help elucidate the involvement of the Av27-sugE gene 
in these mechanisms and also to evaluate the impact 
of this gene in the susceptibility of E. coli cells, MIC 
experiments were performed. The results shown in 
Table 1 revealed that the MICs of E. coli containing the 
Av27-sugE gene generally increased for all the drugs 
tested, when compared with E. coli HB101/pUC19. A 
significant increase (p＜0.05) was observed with EtBr 
(3-fold), CP (2.5-fold), TE (4-fold) and TBT (6-fold) (Ta-
ble 1). These data indicate that the Av27-sugE gene 
affects the intrinsic multidrug resistance of E. coli 
HB101. EtBr is a hydrophobic cationic dye, which can 
be effluxed by SMR (Jack et al., 2000), and that was 
confirmed in the present study. SMR proteins like 
SugE appear to have a broad specificity spectrum that 
include not only the usual set of amphipatic cations, 
but also TE and CP (Jack et al., 2000). Chlorampheni-
col is a neutral antimicrobial that is fairly hydrophilic, 
suggesting its relatively poor membrane permeability 
(Lewis, 2001). Our results also showed that this com-
pound is a substrate for Av27-SugE, possibly promot-
ing its efflux across the cytoplasmic membrane. Con-
Fig. 3. Amino acid sequence alignment of the SugE of A. molluscorum Av27 (Av27), A. hydrophila 7966 (7966) and 
E. coli K12 (K12).
Grey boxes highlight the amino acids found in Av27 and 7966, but not in K12. Symbols: *, same chemical classifica-
tion; °, different chemical classification; open box, amino acid at position 24, known to play a role in substrate specific-
ity.
Table 1. Susceptibility of E. coli HB101/Av27-sugE and E. coli HB101/pUC19 to different classes of drugs.
Type of drug Drug MW miLogP
MIC (µg ml-1)
E. coli HB101/Av27-sugE E. coli HB101/pUC19
Cationic dyes
Ethidium bromide (EtBr) 394.34 0.304 422* 164
Proflavine (PF) 209.25 1.269  31  23
Crystal violet (CV) 408.03 3.196  14   6
Cetylpiridinium chloride (CPC) 340.05 3.027  16  16
Neutral antimicrobial Chloramphenicol (CP) 323.16 0.731   5*   2
Other antimicrobial Tetracycline (TE) 444.44 -0.69   3*   1
Organotins
Tributyltin (TBT) 325.55 3.458 320*  53
Dibutyltin (DBT) 303.88 2.601   7   5
* A value of p＜0.05 was considered significant. MW: molecular weight; miLogP: octanol-water partition coefficient logP.
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sidering TE, this drug forms a complex with divalent 
metals such as magnesium, which is excreted from 
the cell by efflux systems (Nonaka and Suzuki, 2002). 
The extrusion of TE by efflux is a common resistance 
mechanism. Accordingly, different tetracycline-pump 
families are known (Nonaka and Suzuki, 2002). In the 
present work, the resistance to TE increased due to 
the presence of the Av27-sugE gene, suggesting that 
sugE is possibly responsible for the efflux of the 
TE-Sn2+ complex.
Moriguchi LogP (miLogP) is a physicochemical fac-
tor of hydrophobicity and bioavailability of chemicals 
(Lipinski et al., 2001). Table 1 shows a comparison of 
the miLogP values with the increase of resistance. All 
of the tested compounds studied showed similar mo-
lecular size (ca. 200‒400); nonetheless the miLogP 
values were separated into two groups. One group in-
cludes compounds with a significant increase of the 
MIC value (EtBr, CP, TE) and with lower miLogP values 
whereas the other group includes drugs with higher 
miLogP values. An exception was observed for TBT. 
Since TBT is a lipophilic and amphipathic compound 
with a higher miLogP value, it is expected that its ac-
tion on bacteria will be similar to that of proflavine, 
crystal violet, cetylpiridinium chloride and dibutyltin. 
However, Av27-sugE might also recognize TBT as an 
efflux substrate, and therefore the exclusion of the 
compound from the cell will contribute to the TBT re-
sistance observed in this strain.
Concluding Remarks
From the available literature a number of mecha-
nisms contributing to TBT resistance have been de-
scribed and seem to be present within the same strain 
and also among different strains and species (Dubey 
et al., 2006; Hernould et al., 2008; Kawai et al., 1998). 
Some of the mechanisms might be activated at differ-
ent phases of the bacterial growth and/or when cells 
are exposed to different TBT concentrations. Likewise, 
in A. hydrophila it was suggested that in addition to the 
AheABC system, other RND-type efflux pumps con-
tribute to the intrinsic drug resistance observed in this 
species (Hernould et al., 2008).
All together, our data support the involvement of the 
Av27-sugE gene in the resistance of A. molluscorum 
Av27 to TBT. The relative expression of the Av27-sugE 
gene is increased at the early growth phase when a 
high concentration of TBT is present. Additionally, 
Av27-sugE increased the intrinsic multidrug resistance 
of E. coli HB101 to EtBr, CP, TE and specifically to TBT. 
Moreover the aa substitution at position 24 of Av27-
SugE supports the modelling data performed, rein-
forcing the specificity of Av27-SugE for TBT.
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